Register

Registration

Note : After Answered of Questionnaires / Survey Please Close it.
.

Ishita Drugs & Industries Ltd . Small Cap

BSE: 524400 | NSE:
Pharmaceuticals
Live
20/04/2021 4:00:00 PM
33.50 1.00   (3.08%)
BSE: price shown with 5 mins delayed.
Prev. Close 32.50
Open Price 33.50
Volume Traded 110.00

Fundamentals

Mar'11 Mar'12 Mar'13 Mar'14 Mar'15 Mar'16 Mar'17 Mar'18 Mar'19 Mar'20
Ajusted EPS(Rs.)
Net Sales (Rs. Cr.)
Adjusted Net Profit
Book Value/ Share(Rs.)
Cash Flow
Debt to Cash Flow from Operations
RONW
ROCE %
Net Operating Profit Margin %
Net Profit Margin %
Debt / Equity
Dividend Yield %
Mar'11 Mar'12 Mar'13 Mar'14 Mar'15 Mar'16 Mar'17 Mar'18 Mar'19 Mar'20
Ajusted EPS(Rs.) 1.3 0.69 1.4 0.68 0.74 0.46 0.61 0.83 1.18 1.83
Net Sales (Rs. Cr.) 8.83 5.36 11.76 7.34 7.54 7.1 6.44 6.9 9.09 14.83
Adjusted Net Profit 0.41 0.21 0.41 0.22 0.22 0.14 0.18 0.24 0.34 0.54
Book Value/ Share(Rs.) 14.85 15.55 16.95 17.63 18.38 18.83 19.44 20.27 21.45 23.28
Cash Flow -1.72 0.31 0.18 0.31 -0.30 1.05 -1.08 0.08 -0.18 -0.01
Debt to Cash Flow from Operations -0.28 0.06 -0.86 0.26 0.82 4.35 0.02 0.18 0.25 0.28
RONW 0.00 0.00 8.64 3.87 4.09 2.52 3.15 4.21 5.61 8.23
ROCE % 13.72 7.19 12.85 6.16 5.98 4.21 4.61 7.33 8.13 10.82
Net Operating Profit Margin % 7.47 7.28 5.95 5.72 5.84 4.93 6.21 6.67 6.82 6.00
Net Profit Margin % 4.42 3.92 3.57 2.72 2.92 1.97 2.80 3.62 3.85 3.71
Debt / Equity 0.05 0.04 0.02 0.04 0.03 0.11 0.10 0.01 0.03 0.04
Dividend Yield % 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Year on Year Growth Rate (%)

Ajusted EPS Sales Adjusted Net Profit

Latest Financials

Standalone Consolidated
TTM EPS (Rs) 1.85
TTM Sales (Rs. Cr.) 13.3
BVPS (Rs.) 24.09
Reserves (Rs. Cr.) 4.21
P/BV 1.39
PE 17.57
From the Market
52 Week High / Low (Rs) 35.2/10.5
All Time High / Low (Rs) 80.45/0.1
Volume Traded 110
Market Cap (Rs. Cr.) 9.72
Equity (Rs. Cr.) 2.99
Face Value (Rs) 10
Industry PE 0

Quarterly Results

Mar'2020 Jun'2020 Sep'2020 Dec'2020
Net Sales (Cr) 3.37 2.30 3.80 3.83
Adjusted EPS (Rs) 0.57 0.30 0.50 0.47
Net Profit Margin % 5.04 3.91 3.95 3.66
Mar'2020 Jun'2020 Sep'2020 Dec'2020
Net Sales (Cr)
Adjusted EPS (Rs)
Net Profit Margin %

Quarterly Growth Rate (%)

Ajusted EPS Sales Net Profit Margin

Peers Data

Name Current Price(Rs) Market Cap. (Rs. cr.) Net Profit(Rs. cr.) Sales Growth(%)

Technical

Sector

23387.09 280.75   (1.22%)

Index

47705.80 -243.62   (-0.51%)
9 Days Avg
Span A Span B 52 Week TenKan-Sen Kijun-Sen ChiKou-Sen
9 Days Avg

Score

Kindly subscribe to get access

Research Analytical

Kindly subscribe to get access

News

About Company

Ishita Drugs & Industries was incorporated in Feb.'92 by Jagdish Agarwal. The company set up a project to manufacture bulk drugs at Sanand, in the Ahmedabad district of Gujarat with an installed capacity of 408 tpa. Commercial production commenced in Jan.'95.Recession in some international markets and intense dumping of the Chinese exporters of the bulk drugs originally planned in the product range, necessiated a review by the company of its production programme and product range. It decided to undertake production of fluoro-quinolones, the latest broad spectrum anti-bacterials. The company established an in-house R&D laboratory which has developed a highly improved process technology for norfloxacin. The in-house process technology for norfloxacin was implemented in its plant in Oct.'95.